Integrating financial risk into cardiometabolic prevention: from price transparency to patient-level insights into diabetes-related spending
Pearcy, P., Nasir, K. & Mossialos, E.
(2026).
Integrating financial risk into cardiometabolic prevention: from price transparency to patient-level insights into diabetes-related spending.
American Journal of Preventive Cardiology,
https://doi.org/10.1016/j.ajpc.2026.101444
[In Press]
(2026).
Integrating financial risk into cardiometabolic prevention: from price transparency to patient-level insights into diabetes-related spending.
American Journal of Preventive Cardiology,
https://doi.org/10.1016/j.ajpc.2026.101444
[In Press]
Abstract
Cardiometabolic disease remains a leading driver of morbidity, mortality, and healthcare costs in the United States. While clinical risk models have advanced, parallel frameworks to quantify financial exposure and vulnerability remain underdeveloped. Such insights are critical to support risk-informed coverage design and development of cost-effective interventions within cardiometabolic care pathways.
